Zynex, Inc. (ZYXI)

Market Cap	262.73M
Revenue (ttm)	193.67M
Net Income (ttm)	4.82M
Shares Out	31.85M
EPS (ttm)	0.15
PE Ratio	55.86
Forward PE	22.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	321,297
Open	8.28
Previous Close	8.40
Day's Range	8.21 - 8.72
52-Week Range	7.15 - 13.77
Beta	0.53
Analysts	Strong Buy
Price Target	14.00 (+69.7%)
Earnings Date	Oct 24, 2024

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI
• Website: https://www.zynex.com

Financial Performance

In 2023, Zynex's revenue was $184.32 million, an increase of 16.54% compared to the previous year's $158.17 million. Earnings were $9.73 million, a decrease of -42.91%.

Analyst Forecast

According to 2 analysts, the average rating for ZYXI stock is "Strong Buy." The 12-month stock price forecast is $14.0, which is an increase of 69.70% from the latest price.

Price Target

$14.0

(69.70% upside)

Analyst Consensus: Strong Buy